staurosporine has been researched along with Arterial Occlusive Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chopp, M; Jiang, N; Li, Y | 1 |
| Ahlemeyer, B; Culmsee, C; Junker, V; Kouklei, M; Krieglstein, J; Ravati, A | 1 |
2 other study(ies) available for staurosporine and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Increase in apoptosis and concomitant reduction of ischemic lesion volume and evidence for synaptogenesis after transient focal cerebral ischemia in rat treated with staurosporine.
Topics: Animals; Apoptosis; Arterial Occlusive Diseases; Brain; Enzyme Inhibitors; In Situ Nick-End Labeling; Ischemic Attack, Transient; Male; Neuronal Plasticity; Rats; Rats, Wistar; Staurosporine; Synapses | 1999 |
Enalapril and moexipril protect from free radical-induced neuronal damage in vitro and reduce ischemic brain injury in mice and rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Arterial Occlusive Diseases; Blood Pressure; Brain; Brain Ischemia; Carcinogens; Cells, Cultured; Cerebral Arteries; Chick Embryo; Dose-Response Relationship, Drug; Enalapril; Ferric Compounds; Ferrous Compounds; Free Radical Scavengers; Free Radicals; Glutamic Acid; Isoquinolines; Male; Mice; Mice, Inbred Strains; Neurons; Neuroprotective Agents; Rats; Rats, Long-Evans; Staurosporine; Tetrahydroisoquinolines | 1999 |